Asbestos and the pleura: A review

Chest

Volumn 125, Issue 3, 2004, Pages 1103-1117

  Cugell, David W ^a,b   Kamp, David W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Rehabilitation Institute   (United States)

Author keywords

Asbestos; Asbestos production; DNA damage; Mesothelioma; Plaque; Pleura; Pleural calcification; Pleural fibrosis; Public policy; Reactive nitrogen species; Reactive oxygen species; Rounded atelectasis; Simian virus 40

Indexed keywords

ASBESTOS;

ATELECTASIS; CLEARANCE; GEOGRAPHY; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; MESOTHELIOMA; MINERALOGY; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PLEURA EFFUSION; PLEURA PLAQUE; PLEURA THICKENING; PLEURAL FIBROSIS; PRIORITY JOURNAL; REVIEW; THORAX DISEASE; THORAX RADIOGRAPHY; TOBACCO;

EID: 1642362408     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.3.1103     Document Type: Review

References (120)

1. Albin M, Magnani C, Krstev S, et al. Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect 1999; 107:289-298
2. Berry G, Newhouse ML, Wagner JC. Mortality from all cancers of asbestos factory workers in east London 1933-80. Occup Environ Med 2000; 57:782-785
3. Hansen J, de Klerk NH, Musk AW, et al. Environmental exposure to crocidolite and mesothelioma: exposure-response relationships. Am J Respir Crit Care Med 1998; 157:69-75
4. Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997; 145:211-218
5. Berenson A. Asbestos accord is said to be near. New York Times, April 24, 2003
6. Editorial. The asbestos burden [editorial]. Chicago Tribune, September 25, 2002
7. Sider L, Holland EA, Davis TJ, et al. Changes on radiographs of wives of workers exposed to asbestos. Radiology 1987; 164:723-726
8. Volk S. Ancient uses of asbestos. Available at: http://www.iras.ucalgary. ca/~volk/sylvia/Asbestos.htm. Accessed February 19, 2004
9. Buckingham D, Virta R. Asbestos statistics and information. Available at: http://minerals.usgs.gov/minerals/pubs/commodity/asbestos. Accessed February 19, 2004
10. Brownson T. Current and historical American asbestos regulations. Monaldi Arch Chest Dis 1998; 53:181-185
11. Tweedale G, Hansen P. Protecting the workers: the medical board and the asbestos industry, 1930s-1960s. Med Hist 1998; 42:439-457
12. Murray M. Departmental Committee for Compensation for Industrial Diseases, CND 3495 & 3496. London, UK: HMSO, 1907
13. Merewether ERA, Price CW. Report on effects of asbestos on the lungs and dust suppression in the asbestos industry. London, UK: HMSO, 1930
14. Parkes WR. Occupational lung disorders. 2nd ed. London, UK: Butterworths, 1974; 249
15. Enterline PE. Changing attitudes and opinions regarding asbestos and cancer 1934-1965. Am J Ind Med 1991; 20:685-700
16. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960; 17:260-271
17. Voisin C, Marin I, Brochard P, et al. Environmental airborne tremolite asbestos pollution and pleural plaques in Afghanistan. Chest 1994; 106:974-976
18. Selikoff IJ, Hammond EC. Environmental epidemiology: 3. Community effects of nonoccupational environmental asbestos exposure. Am J Public Health 1968; 58:1658-1666
19. Noro L. Occupational and "non-occupational" asbestosis in Finland. Am Ind Hyg Assoc J 1968; 29:195-201
20. Rous V, Studeny J. Aetiology of pleural plaques. Thorax 1970; 25:270-284
21. Constantopoulos SH, Theodoracopoulos P, Dascalopoulos G, et al. Metsovo lung outside Metsovo: endemic pleural calcifications in the ophiolite belts of Greece. Chest 1991; 99:1158-1161
22. Dumortier P, Goeman L, Laurent K, et al. The role of environmental and occupational exposures in Turkish immigrants with fibre-related disease. Eur Respir J 2001; 17:922-977
23. Fitzgerald EF, Stark AD, Vianna N, et al. Exposure to asbestiform minerals and radiographic chest abnormalities in a talc mining region of upstate New York. Arch Environ Health 1991; 46:151-154
24. Kuku O, Parker DL. Diagnosis and management of asbestosis. Minn Med 2000; 83:47-49
25. Polissar L, Severson RK, Boatman ES. A case-control study of asbestos in drinking water and cancer risk. Am J Epidemiol 1984; 119:456-471
26. Toft P, Meek ME. Asbestos in drinking water: a Canadian view. Environ Health Perspect 1983; 53:177-180
27. Roggli VL, Sanders LL. Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg 2000; 44:109-117
28. McFadden D, Wright J, Wiggs B, et al. Cigarette smoke increases the penetration of asbestos fibers into airway walls. Am J Pathol 1986; 123:95-99
29. Sekhon H, Wright J, Churg A. Effects of cigarette smoke and asbestos on airway, vascular and mesothelial cell proliferation. Int J Exp Pathol 1995; 76:411-418
30. Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982; 247:617-622
31. Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987; 71:113-121
32. Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med 1998; 338:1565-1571
33. Landrigan PJ. Asbestos: still a carcinogen. N Engl J Med 1998; 338:1618-1619
34. Mossman BT, Bignon J, Corn M, et al. Letter to the editor. Science 1990; 248:799-801
35. Osinubi OY, Gochfeld M, Kipen HM. Health effects of asbestos and nonasbestos fibers. Environ Health Perspect 2000; 108:665-674
36. Asbestos in public and commercial buildings: a literature review and synthesis of current knowledge. Health Effects Institute-Asbestos Research, 1991; 8-10
37. Mossman BT, Bignon J, Corn M, et al. Asbestos: scientific developments and implications for public policy. Science 1990; 247:294-301
38. Robinson BW, Musk AW. Benign asbestos pleural effusion: diagnosis and course. Thorax 1981; 36:896-900
39. Light RW. Pleural diseases. 3rd ed. Baltimore, MD: Williams & Wilkins, 1995
40. Becklake MR, Cowie RL. Pneumoconioses. In: Murray J, Nadel J, Mason R, et al, eds. Textbook of respiratory medicine. Philadelphia, PA: Saunders, 2000; 1839-1840
41. Eisenstadt HB. Pleural effusion in asbestosis [letter]. N Engl J Med 1974; 290:1025
42. Knisely BL, Broderick LS, Kuhlman JE. MR imaging of the pleura and chest wall. Magn Reson Imaging Clin N Am 2000; 8:125-141
43. Ferrer J, Balcells E, Orriols R, et al. Derrame pleural benigno por asbesto: descripcion de la primera serie en Espana. Med Clin (Bare) 1996; 107:535-538
44. Cohen M, Sahn SA. Resolution of pleural effusions. Chest 2001; 119:1547-1562
45. Gaensler EA, Kaplan AI. Asbestos pleural effusion. Ann Intern Med 1971; 74:178-191
46. Goldsmith JR. Asbestos as a systemic carcinogen: the evidence from eleven cohorts. Am J Ind Med 1982; 3:341-348
47. Kagan E, Jacobson RJ. Lymphoid and plasma cell malignancies: asbestos-related disorders of long latency. Am J Clin Pathol 1983; 80:14-20
48. Sprince NL, Oliver LC, McLoud TC, et al. Asbestos exposure and asbestos-related pleural and parenchymal disease: associations with immune imbalance. Am Rev Respir Dis 1991; 143:822-828
49. Dodson RF, Williams MG Jr, Corn CJ, et al. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis 1990; 142:843-847
50. Greene R, Schaefer CM, Oliver LC. Improved detection of asbestos-related pleural plaques with digital radiography. Ann N Y Acad Sci 1991; 643:90-96
51. Svenes KB, Borgersen A, Haaversen O, et al. Parietal pleural plaques: a comparison between autopsy and X-ray findings. Eur J Respir Dis 1986; 69:10-15
52. Ren H, Lee DR, Hruban RH, et al. Pleural plaques do not predict asbestosis: high-resolution computed tomography and pathology study. Mod Pathol 1991; 4:201-209
53. Gilmartin D. The serratus anterior muscle on chest radiographs. Radiology 1979; 131:629-635
54. To B or not to B: a NIOSH B reader. National Institute of Occupational Safety and Health. Available at: http://www.cdc.gov/niosh/pamphlet.html. Accessed February 19, 2004
55. Ducatman AM. Variability in interpretation of radiographs for asbestosis abnormalities: problems and solutions. Ann N Y Acad Sci 1991; 643:108-120
56. Jones RN, McLoud T, Rockoff SD. The radiographic pleural abnormalities in asbestos exposure: relationship to physiologic abnormalities. J Thorac Imaging 1988; 3:57-66
57. Schwartz DA, Galvin JR, Dayton CS, et al. Determinants of restrictive lung function in asbestos-induced pleural fibrosis. J Appl Physiol 1990; 68:1932-1937
58. Bergin CJ. Determinants of restrictive lung function in asbestos-induced pleural fibrosis. J Appl Physiol 1991; 70: 472-473
59. Rosenberg DM. Pleural fibrosis and asbestosis. J Appl Physiol 1991; 70:473-475
60. Rockoff SD, Chu J, Rubin LJ. Special report: asbestos-induced pleural plaques; a disease process associated with ventilatory impairment and respiratory symptoms. Clin Pulm Med 2002; 9:113-124
61. Edge JR. Incidence of bronchial carcinoma in shipyard workers with pleural plaques. Ann N Y Acad Sci 1979; 330:289-294
62. Harber P, Mohsenifar Z, Oren A, et al. Pleural plaques and asbestos-associated malignancy. J Occup Med 1987; 29:641-644
63. Weiss W. Asbestos-related pleural plaques and lung cancer. Chest 1993; 103:1854-1859
64. Hillerdal G. Pleural and parenchymal fibrosis mainly affecting the upper lung lobes in persons exposed to asbestos. Respir Med 1990; 84:129-134
65. McGavin CR, Sheers G. Diffuse pleural thickening in asbestos workers: disability and lung function abnormalities. Thorax 1984; 39:604-607
66. Lilis R, Miller A, Godbold J, et al. Radiographic abnormalities in asbestos insulators: effects of duration from onset of exposure and smoking: relationships of dyspnea with parenchymal and pleural fibrosis. Am J Ind Med 1991; 20:1-15
67. Copley SJ, Wells AU, Rubens MB, et al. Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 2001; 220:237-243
68. Kee ST, Gamsu G, Blanc P. Causes of pulmonary impairment in asbestos-exposed individuals with diffuse pleural thickening. Am J Respir Crit Care Med 1996; 154:789-793
69. Batra P, Brown K, Hayashi K, et al. Rounded atelectasis. J Thorac Imaging 1996; 11:187-197
70. Mintzer RA, Cugell DW. The association of asbestos-induced pleural disease and rounded atelectasis. Chest 1982; 81:457-460
71. Hillerdal G. Rounded atelectasis: clinical experience with 74 patients. Chest 1989; 95:836-841
72. McDonald JC, Sebastien P, McDonald AD, et al. Case B: epidemiological observations on mesothelioma and their implications for non-occupational exposure. IARC Sci Publ 1989; 90:420-427
73. Kielkowski D, Nelson G, Rees D. Risk of mesothelioma from exposure to crocidolite asbestos: a 1995 update of a South African mortality study. Occup Environ Med 2000; 57:563-567
74. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996; 9:1932-1942
75. Hofmann J, Mintzer D, Warhol MJ. Malignant mesothelioma following radiation therapy. Am J Med 1994; 97:379-382
76. Kramer G, Gans S, Rijnders A, et al. Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with 90yttrium-silicate. Lung Cancer 2000; 27:205-208
77. Hillerdal G, Berg J. Malignant mesothelioma secondary to chronic inflammation and old scars: two new cases and review of the literature. Cancer 1985; 55:1968-1972
78. Jackson JH, Schraufstatter IU, Hyslop PA, et al. Role of oxidants in DNA damage: hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J Clin Invest 1987; 80:1090-1095
79. Berry G. Mortality of workers certified by pneurnoconiosis medical panels as having asbestosis. Br J Ind Med 1981; 38:130-137
80. Mossman BT, Gruenert DC. SV40, growth factors, and mesothelioma: another piece of the puzzle. Am J Respir Cell Mol Biol 2002; 26:167-170
81. Young RH, Clement PB. Malignant lesions of the female genital tract and peritoneum that may be underdiagnosed. Semin Diagn Pathol 1995; 12:14-29
82. Carbone M, Fisher S, Powers A, et al. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol 1999; 180:167-172
83. Pass HI, Pogrebniak HW. Malignant pleural mesothelioma. Curr Probl Surg 1993; 30:921-1012
84. Huang H, Reis R, Yonekawa Y, et al. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 1999; 9:33-42
85. Shivapurkar N, Wiethege T, Wistuba II, et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 1999; 76:181-188
86. Bocchetta M, Di Resta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 2000; 97:10214-10219
87. De Luca A, Baldi A, Esposito V, et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nature Med 1997; 3:913-916
88. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 1983; 77:321-343
89. Boutin C, Schlesser M, Frenay C, et al. Malignant pleural mesothelioma. Eur Respir J 1998; 12:972-981
90. Mossman BT, Kamp DW, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 1996; 14:466-480
91. Light R. Tumors of the pleura. 2nd ed. New York, NY: Saunders, 1994
92. Muller N. Imaging of the pleura [review]. Radiology 1993; 186:297-309
93. Beauchamp HD, Kundra NK, Aranson R, et al. The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura. Chest 1992; 102:1110-1112
94. Boutin C, Key F, Gouvernet J, et al. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients; part 2. Prognosis and staging. Cancer 1993; 72:394-404
95. Wilsher ML, Veale AG. Medical thoracoscopy in the diagnosis of unexplained pleural effusion. Respirology 1998; 3:77-80
96. Kamp DW, Mossman BT. Asbestosis associated cancers: clinical spectrum and pathogenic mechanisms. Clin Occup Environ Med 2002; 2:753-757
97. Shrager JSD, Kaiser L. Surgery and staging of mesothelioma. London, UK: Martin Dunitz, 2002
98. Zellos LS, Sugarbaker DJ. Multimodality treatment of diffuse malignant pleural mesothelioma. Semin Oncol 2002; 29:41-50
99. Shukula A, Her T, Kamp DW, et al. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 2003; 34:1117-1129
100. Roberts GH. The pathology of parietal pleural plaques. J Clin Pathol 1971; 24:348-353
101. Bateman ED, Benatar SR. Asbestos-induced diseases: clinical perspectives. Q J Med 1987; 62:183-194
102. Salin SA, Antony VB. Pathogenesis of pleural plaques: relationship of early cellular response and pathology. Am Rev Respir Dis 1984; 130:884-887
103. Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax 1999; 54:638-652
104. Quinlan TR, BeruBe KA, Hacker MP, et al. Mechanisms of asbestos-induced nitric oxide production by rat alveolar macrophages in inhalation and in vitro models. Free Radic Biol Med 1998; 24:778-788
105. Chao CC, Park SH, Aust AE. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch Biochem Biophys 1996; 326:152-157
106. Jaurand MC. Mechanisms of fiber-induced genotoxicity. Environ Health Perspect 1997; 105:1073-1084
107. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nature Cell Biol 2001; 3:E255-E263
108. Bortner CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol 2002; 42:259-281
109. BeruBe KA, Quinlan TR, Fung H, et al. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am J Respir Cell Mol Biol 1996; 15:141-147
110. Broaddus VC, Yang L, Scavo LM, et al. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J Clin Invest 1996; 98:2050-2059
111. Hoidal JR. Reactive oxygen species and cell signaling. Am J Respir Cell Mol Biol 2001; 25:661-663
112. +/- mice. Toxicol Sci 2002; 68:331-338
113. Heintz NH, Janssen YM, Mossman BT. Persistent induction of c-fos and c-jun expression by asbestos. Proc Natl Acad Sci U S A 1993; 90:3299-3303
114. Reilly W. Environmental quality: responses from industry and government; is environmental quality good for business? Washington, DC: American Enterprise Institute for Public Policy Research, 1990
115. Krump KS. Letter to the editor. Science 1990; 248:799
116. Cordier S, Lazar P, Brochard P, et al. Epidemiologic investigation of respiratory effects related to environmental exposure to asbestos inside insulated buildings. Arch Environ Health 1987; 42:303-309
117. Schwartz VE, Lorber L. A letter to the nation's trial judges: how the focus on efficiency is hurting you and innocent victims in asbestos liability cases. Am J Trial Advocacy 2000; 24:24 247-268
118. Mitchell RS, Chase GR, Kotin PI. Evaluation for compensation of asbestos-exposed individuals. J Occup Med 1985; 27:95-109
119. Cocchiarelia L, Anderson G. Guides to the evaluation of permanent impairment. 5th ed. Chicago. IL: American Medical Association, 2001
120. American Bar Association. Commission on Asbestos Litigation. Chicago, December 18-19, 2002